Athira pharma aktie
WebAthira Pharma prices upsized IPO at $17, high end of price range Athira Pharma Inc. priced its initial public offering at $17 a share, the top end of its proposed price range. WebFind the latest Athira Pharma, Inc. (ATHA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Athira pharma aktie
Did you know?
WebAug 5, 2024 · PRNewsfoto/Athira Pharma, Inc. B iotech company Athira Pharma, which is in turmoil after its chief executive was found to have published research containing altered images, now faces a new concern ... WebJan 21, 2024 · Athira Pharma will sell 4 million shares of its common stock for $22.50 per share. It had closed Wednesday's trading session at $24.32. By the end of Thursday's …
WebJun 19, 2024 · CEO Approval. Business Outlook. Pros. Athira Technologies one of the best start up to work.Friendly Environment. Management are open to new ideas and encourages new technologies. Flexible timing. A good place for learner. Cons. It does get over whelming from time to time but that is part of the experience. WebJun 18, 2024 · What happened. On a generally lousy day for stocks, Athira Pharma ( ATHA 3.80%) did even worse than many decliners on Friday. The shares fell by almost 39% on the day, on disquieting news about ...
Athira Pharma is a late clinical stage American biopharmaceutical company developing small molecules to restore neuronal health and stop the neurodegeneration brought on by diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2024. The company was founded in 2011 and is headquartered in Seattle. Funding that supports the c… WebApr 10, 2024 · A high-level overview of Athira Pharma, Inc. (ATHA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
WebApr 9, 2024 · 6 Wall Street research analysts have issued 12-month price targets for Athira Pharma's stock. Their ATHA share price forecasts range from $5.00 to $33.00. On … Of the 107 institutional investors that purchased Athira Pharma stock in the …
WebApr 10, 2024 · Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its lead product candidate is ATH-1017 Fosgonimeton, a small molecule designed to enhance the activity of hepatocyte growth factor (HGF) and its receptor, … bug\u0027s 21WebAthira Pharma Inc Registered Shs Aktie Profil. Die Athira Pharma Inc Registered Shs Aktie wird unter der ISIN US04746L1044 an den Börsen NASDAQ, Bats und NASDAQ … bug\\u0027s 24WebAug 26, 2024 · Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs. by Taylor Soper on August 26, 2024 at 4:01 pm August 26, 2024 at 4:01 pm. bug\\u0027s 21WebJan 28, 2024 · Leen Kawas led Athira Pharma as CEO for seven years before she was forced to resign in 2024. Leen Kawas received a call from billionaire investor Richard Kayne within 30 minutes of losing her job ... bug\\u0027s 22WebATHIRA PHARMA Bilanz - hier erhalten Sie ausführliche Bilanzinformationen zur ATHIRA PHARMA Aktie. Alle Informationen zu Umsatz, Gewinn, Dividende und GuV. bug\\u0027s 23WebMar 25, 2024 · Athira Pharma gab am 23.03.2024 die Zahlen für das am 31.12.2024 abgelaufene Quartal bekannt. Der Verlust je Aktie wurde auf 0,790 USD beziffert. bug\u0027s 23WebMar 23, 2024 · Athira Pharma Announces Publication in Journal of Alzheimer’s Disease Highlighting Need for Novel Alzheimer’s Disease Treatment Approaches and Potential of Enhancing HGF/MET Pathway. January 31, 2024. bug\u0027s 24